CELUW (Celularity) FCF Margin %: -124.34% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CELUW Celularity Inc CELUW
38 GF Score
Price $0.01
! 6 Warning Signs
View Full Analysis

What is Celularity FCF Margin %?

Celularity CELUW 38 FCF Margin % is -124.34% as of Dec. 2025. GuruFocus rates CELUW with a GF Score™ of 38/100. The stock has 6 warning signs investors should review. Among 960 Biotechnology companies, Celularity ranks better than 54.27% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Celularity's Free Cash Flow for the three months ended in Dec. 2025 was $-5.10 Mil. Celularity's Revenue for the three months ended in Dec. 2025 was $4.10 Mil. Therefore, Celularity's FCF Margin % for the quarter that ended in Dec. 2025 was -124.34%.

As of today, Celularity's current FCF Yield % is -29.73%.

The historical rank and industry rank for Celularity's FCF Margin % or its related term are showing as below:


During the past 6 years, the highest FCF Margin % of Celularity was -12.10%. The lowest was -796.17%. And the median was -366.39%.

CELUW's FCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -76.29
* Ranked among companies with meaningful FCF Margin % only.

Celularity FCF Margin % Related Terms

Celularity FCF Margin % Historical Data

* Premium members only.

The historical data trend for Celularity's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Celularity FCF Margin % Chart

Celularity Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial -545.11 -796.17 -187.66 -12.10 -49.92

Celularity Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.29 -26.19 -17.42 -78.71 -124.34

CELUW vs HOWL, MGX, TVGN: FCF Margin % Comparison

For the Biotechnology subindustry, Celularity's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Celularity FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Celularity's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Celularity's FCF Margin % falls into.


CELUW
38GF Score
Celularity Inc CELUW
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Celularity FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Celularity's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-13.254/26.55
=-49.92 %

Celularity's FCF Margin for the quarter that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-5.103/4.104
=-124.34 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -124.34% mean?
Celularity (CELUW) has a FCF Margin % of -124.34% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Celularity and its competitors. According to the industry distribution chart, Celularity ranks #439 out of 960 companies in the Biotechnology industry, placing it in the top 45.7%.
Is Celularity's FCF Margin % too high?
Celularity's current FCF Margin % is -124.34%. Based on the distribution chart, Celularity ranks #439 out of 960 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Celularity has a GF Score™ of 38/100, reflecting its overall financial health beyond just this single metric.
How does Celularity's FCF Margin % compare to HOWL and MGX?
According to the Biotechnology industry distribution chart, Celularity ranks #439 out of 960 companies for FCF Margin %. This puts Celularity in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Celularity and its competitors. Celularity's current FCF Margin % is -124.34%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Celularity stock overvalued right now?
Celularity (CELUW) has a current FCF Margin % of -124.34%. The current FCF Margin % is -124.34%. Celularity's overall GF Score™ is 38/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Celularity (CELUW), the current FCF Margin % is -124.34% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Celularity Business Description

Other Exchanges CELU:USA
Address 170 Park Avenue, Florham Park, NJ, USA, 07932
Celularity Inc is a regenerative and cellular medicine company focused on developing placental-derived allogeneic cell therapies and biomaterial products for the treatment of degenerative diseases, aging-related conditions, cancer, and immune disorders. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. It generates the majority of its revenue from the Degenerative Disease segment.
38GF Score

Get the complete analysis for CELUW

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.01
Price